Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 15/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24216737 | 1.00 | HDAC6 (0.50) | HDAC6HDAC1HDAC3HDAC2 | |
| SCHEMBL25350761 | 0.98 | HDAC6 (0.50) | HDAC6HDAC1HDAC3HDAC2 | |
| SCHEMBL25349300 | 0.97 | HDAC6 (0.49) | HDAC6HDAC1HDAC3HDAC2 | |
| SCHEMBL25351995 | 0.94 | HDAC6 (0.49) | HDAC6HDAC1 | |
| SCHEMBL25350887 | 0.92 | HDAC6 (0.50) | HDAC6HDAC1 | |
| SCHEMBL25350210 | 0.92 | HDAC1 (0.53) | HDAC6HDAC1 | |
| SCHEMBL25350838 | 0.91 | HDAC6 (0.47) | HDAC6HDAC1HDAC3HDAC2 | |
| SCHEMBL24216700 | 0.91 | HDAC1 (0.43) | HDAC6HDAC1 | |
| SCHEMBL30409355 | 0.91 | HDAC1 (0.43) | HDAC6HDAC1 | |
| SCHEMBL25351878 | 0.90 | HDAC1 (0.51) | HDAC6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4185586-A1 | NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Chong Kun Dang Pharmaceutical Corp. (KR) | 2023-05-31 | — | — | EP | disclosed |
| CN-116133658-A | Novel compounds as inhibitors of histone deacetylase 6 and pharmaceutical compositions comprising the same | 株式会社 钟根堂 | 2023-05-16 | — | — | CN | disclosed |